MicroViable Therapeutics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
Later Stage VC
- Investors
-
3
MicroViable Therapeutics General Information
Description
Developer of a microbiota-based therapeutics platform intended to store and preserve intestinal microbiota. The company's therapeutics specializes in microbiota kits designed to keep the anaerobic conditions of stool samples during the process of sample collection and transport, creating the desired environment for the intestinal microbes to survive, enabling healthcare professionals to collect samples following protocols and procedures in stool collection without the need to freeze samples.
Contact Information
Website
www.microviable.comCorporate Office
- Calle Los Prados, 166
- Impulsa Building. Scientific Park
- 33203 Gijón
- Spain
Corporate Office
- Calle Los Prados, 166
- Impulsa Building. Scientific Park
- 33203 Gijón
- Spain
MicroViable Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 01-Dec-2024 | Completed | Pre-Clinical Trials | |||
| 4. Later Stage VC | 06-Sep-2023 | Cancelled | Pre-Clinical Trials | |||
| 3. Later Stage VC | 21-Apr-2022 | Completed | Pre-Clinical Trials | |||
| 2. Later Stage VC | 29-Jul-2021 | $236K | $353K | Completed | Startup | |
| 1. Angel (individual) | 01-Oct-2018 | $117K | $117K | Completed | Startup |
MicroViable Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 1,040 | $1.093259 | $52.55 | $52.55 | 1x | $52.55 | 3.26% | |
| Ordinary | 5,000 | $1.093259 | $21.87 | $21.87 | 1x | $21.87 | 15.68% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
MicroViable Therapeutics Comparisons
Industry
Financing
Details
MicroViable Therapeutics Competitors (4)
One of MicroViable Therapeutics’s 4 competitors is Enterome, a Venture Capital-Backed company based in Paris, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Enterome | Venture Capital-Backed | Paris, France | ||||
| MaaT Pharma | Formerly VC-backed | Lyon, France | ||||
| Biose Industrie | Private Equity-Backed | Aurillac, France | ||||
| Natur's Way Probiotics | Corporation | Horton, KS |
MicroViable Therapeutics Patents
MicroViable Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4606380-A1 | Method for fecal microbiome purification and uses thereof | Inactive | 22-Feb-2024 | ||
| EP-4630020-A1 | Method for fecal microbiome purification and uses thereof | Active | 22-Feb-2024 | ||
| EP-4630020-B1 | Method for fecal microbiome purification and uses thereof | Active | 22-Feb-2024 | ||
| EP-4630020-C0 | Method for fecal microbiome purification and uses thereof | Active | 22-Feb-2024 | ||
| WO-2025141228-A1 | Method for fecal microbiome purification and uses thereof | Pending | 22-Feb-2024 | A61K35/37 |
MicroViable Therapeutics Signals
MicroViable Therapeutics Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Corporación Alimentaria Peñasanta (Spanish) | Corporate Venture Capital | Minority | ||
| Inmunomet | Corporation | Minority | ||
| PADEInvest Group | Venture Capital | Minority |
MicroViable Therapeutics FAQs
-
When was MicroViable Therapeutics founded?
MicroViable Therapeutics was founded in 2016.
-
Where is MicroViable Therapeutics headquartered?
MicroViable Therapeutics is headquartered in Gijón, Spain.
-
What is the size of MicroViable Therapeutics?
MicroViable Therapeutics has 19 total employees.
-
What industry is MicroViable Therapeutics in?
MicroViable Therapeutics’s primary industry is Drug Discovery.
-
Is MicroViable Therapeutics a private or public company?
MicroViable Therapeutics is a Private company.
-
What is MicroViable Therapeutics’s current revenue?
The current revenue for MicroViable Therapeutics is .
-
How much funding has MicroViable Therapeutics raised over time?
MicroViable Therapeutics has raised $1.98M.
-
Who are MicroViable Therapeutics’s investors?
Corporación Alimentaria Peñasanta (Spanish), Inmunomet, and PADEInvest Group have invested in MicroViable Therapeutics.
-
Who are MicroViable Therapeutics’s competitors?
Enterome, MaaT Pharma, Biose Industrie, and Natur's Way Probiotics are competitors of MicroViable Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process